GENOMIC HEALTH INC's ticker is GHDX and the CUSIP is 37244C101. A total of 133 filers reported holding GENOMIC HEALTH INC in Q4 2016. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $20,556,000 | +9.7% | 699,415 | +8.0% | 0.00% | 0.0% |
| Q3 2016 | $18,730,000 | +23.9% | 647,646 | +10.9% | 0.00% | +50.0% |
| Q2 2016 | $15,116,000 | +15.6% | 583,742 | +10.5% | 0.00% | 0.0% |
| Q1 2016 | $13,081,000 | -33.9% | 528,113 | -6.1% | 0.00% | -33.3% |
| Q4 2015 | $19,791,000 | +59.1% | 562,234 | -4.4% | 0.00% | +50.0% |
| Q3 2015 | $12,441,000 | -28.7% | 587,927 | -6.3% | 0.00% | -33.3% |
| Q2 2015 | $17,439,000 | +2.4% | 627,528 | +12.6% | 0.00% | 0.0% |
| Q1 2015 | $17,022,000 | -4.4% | 557,178 | +0.0% | 0.00% | 0.0% |
| Q4 2014 | $17,811,000 | +13.5% | 557,114 | +0.5% | 0.00% | 0.0% |
| Q3 2014 | $15,688,000 | +1.8% | 554,141 | -1.5% | 0.00% | 0.0% |
| Q2 2014 | $15,408,000 | +3.4% | 562,336 | -0.6% | 0.00% | 0.0% |
| Q1 2014 | $14,902,000 | -6.1% | 565,755 | +4.3% | 0.00% | 0.0% |
| Q4 2013 | $15,871,000 | +1.7% | 542,240 | +6.2% | 0.00% | 0.0% |
| Q3 2013 | $15,607,000 | -5.5% | 510,364 | -2.0% | 0.00% | 0.0% |
| Q2 2013 | $16,521,000 | – | 521,017 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Baker Brothers Advisors | 13,668,866 | $353,955,000 | 3.71% |
| Camber Capital Management LP | 2,458,100 | $63,652,000 | 3.08% |
| Ghost Tree Capital, LLC | 200,000 | $5,179,000 | 1.50% |
| Tributary Capital Management, LLC | 206,291 | $5,342,000 | 0.78% |
| Motley Fool Asset Management LLC | 131,935 | $3,416,000 | 0.74% |
| CORRADO ADVISORS, LLC | 40,695 | $1,054,000 | 0.68% |
| Broadfin Capital, LLC | 270,400 | $7,002,000 | 0.68% |
| ACUTA CAPITAL PARTNERS, LLC | 48,800 | $1,264,000 | 0.61% |
| Motley Fool Wealth Management, LLC | 123,018 | $3,186,000 | 0.35% |
| TFS CAPITAL LLC | 61,773 | $1,600,000 | 0.29% |